Updated Jul 16, 2026
Aguilar-Cordova Estuardo is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $486K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-12-30 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 50.0K | $8.85 | $442K |
| 2024-12-30 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 50.0K | $8.85 | $442K |
| 2024-12-30 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 50.0K | $9.01 | $450K |
| 2024-12-30 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 50.0K | $9.01 | $450K |
| 2024-12-26 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 50.0K | $8.82 | $441K |
| 2024-12-26 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 50.0K | $8.82 | $441K |
| 2024-12-26 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 50.0K | $8.52 | $426K |
| 2024-12-26 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 50.0K | $8.52 | $426K |
| 2024-12-26 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 100.0K | $9.00 | $900K |
| 2024-12-26 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 100.0K | $9.00 | $900K |
| 2024-12-13 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 200.0K | $10.04 | $2.01M |
| 2024-12-13 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 200.0K | $10.04 | $2.01M |
| 2024-12-13 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 200.0K | $8.53 | $1.71M |
| 2024-12-13 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 200.0K | $8.53 | $1.71M |
| 2024-12-06 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 20.0K | $5.23 | $105K |
| 2024-12-06 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 20.0K | $4.79 | $96K |
| 2024-12-06 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 20.0K | $4.46 | $89K |
| 2024-11-27 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 20.0K | $4.97 | $99K |
| 2024-11-08 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 7.5K | $4.92 | $37K |
| 2024-11-08 | CADL | Candel Therapeutics, Inc. | D — Derivative transaction | 7.5K | $4.92 | $37K |
Aguilar-Cordova Estuardo is a corporate insider — currently tracked as 10% Owner. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($486K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Aguilar-Cordova Estuardo profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.